Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized prophylaxis with simoctocog alfa in adults with severe haemophilia A
2014-002986-30Phase 3Completed
- Sponsor
- Octapharma
- Start
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of simoctocog alfa in hemophilia A, sponsored by Octapharma. Primary endpoint: Annualised total bleeding rate reduction. Started Jun 2015; status: completed.
02
Drugs
simoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2014-002986-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002986-30.